Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market

DR. REDDY'S LABORATORIES LTD.

  • NSE CodeDRREDDYEQ
  • BSE Code500124
  • ISININE089A01031
  • IndustryPharmaceuticals


Company Information

Management

Mr. K Randhir Singh

Head - CSR, Co. Secretary & Comp. Officer

Mr. Mannam Venkata Narasimham

Chief Financial Officer

Mr. Erez Israeli

Chief Executive Officer

Mr. Deepak Sapra

CEO - API & Services

Incorporation Year

24/02/1984

Registered Address

Registered & Corporate Office : 8-2-337, Road No.3, Banjara Hills,
Hyderabad, Telangana - 500034
Tel: 040-49002900
Fax: 040-49002999

Registrar Office

Bigshare Services Pvt. Ltd.
306, Right Wing, 3rd Floor Amrutha Ville, Opp.Yashoda Hospital R
Hyderabad,500082,Telangana
Tel: 040-23374967
Fax: 23370295

Email

shares@drreddys.com

Website

http://www.drreddys.com

Listing

BSE, BSE, BSE, MCXSX, NSE, NSE, NYSE

Corporate News

Dr. Reddy's Lab. - General Updates

14-Nov-2026|4:55PM

Dr. Reddy's Laboratories Limited has informed the Exchange about General Up

Dr. Reddy's Lab. - Disclosure Under Regulation 30 Of ...

14-Nov-2026|4:50PM

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Dr. Reddy's Lab. - Copy of Newspaper Publication

11-Nov-2026|7:27PM

Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Ne

Dr. Reddy's Lab. - Analysts/Institutional Investor Me...

10-Nov-2026|8:09PM

Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule o

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug116.03328.99
Aarti Drug484.504,422.03
Aarti Pharma990.708,983.65
Abbott India26,525.0056,363.77
Accent Micro584.851,403.00

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
Parag Parikh ..1972.331.34
SBI Nifty 50 ..1601.760.77
ICICI Prudent..1293.792.24
ICICI Prudent..1089.272.98
ICICI Prudent..854.391.11

Board Meetings

DatePurpose
23/10/2026Quarterly Results
22/07/2026Quarterly Results
12/05/2026Audited Results
21/01/2026Quarterly Results
24/10/2025Quarterly Results